A kind of madecassoside liposome modified by peg-pcl-peg triblock copolymer and its application

A technology of madecassoside and triblock, which is applied in the field of pharmaceutical preparations, skin care products and daily chemicals, which can solve the problems of drug efficacy and application limitations, and achieve the convenience of skin drug delivery, promotion of healing, and improvement of bioavailability Effect

Active Publication Date: 2020-05-22
SOUTH CHINA UNIV OF TECH
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, because they are polar macromolecules, it is difficult to reach the lesion through the skin epidermis, resulting in certain limitations in their efficacy and application.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of madecassoside liposome modified by peg-pcl-peg triblock copolymer and its application
  • A kind of madecassoside liposome modified by peg-pcl-peg triblock copolymer and its application
  • A kind of madecassoside liposome modified by peg-pcl-peg triblock copolymer and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] (1) Weigh 5.05g MPEG and 10.96gε-CL(n (MPEG) :n (ε-CL) 1:10) and round bottom flask, add 0.08g stannous octoate (Sn(Oct) 2 ) After reacting at 120°C for 12h, add 1.66g HMDI (n (ε-CL) :n (HMDI) The ratio is 10:1) at 80°C for 6h. After purification, the PEG-PCL-PEG triblock polymer (PECE) was obtained, which was vacuum-dried to constant weight for use.

[0054] (2) Weigh 0.50g of PECE, 0.50g of egg yolk lecithin, 0.10g of cholesterol, V E Dissolve 0.05 mL of acetate in 10 mL of dichloromethane to make an organic phase solution;

[0055] (3) Dissolve 20 mg / mL madecassoside solution in the organic phase solution prepared in step (2), and then stir at 500 r / min for 5 min to form a W / O emulsion;

[0056] (4) Transfer the W / O emulsion in step (3) to an eggplant-shaped bottle, and remove the organic solvent by evaporating under reduced pressure with a rotary evaporator; then put the eggplant-shaped bottle into a vacuum drying oven to dry, and remove the remaining After ul...

Embodiment 2

[0058] (1) Weigh 5.05g MPEG and 10.96gε-CL(n (MPEG) :n (ε-CL) 1:10) and round bottom flask, add 0.08g stannous octoate (Sn(Oct) 2 ) After reacting at 120°C for 12h, add 1.66g HMDI (n (ε-CL) :n (HMDI) The ratio of 10:1) was reacted at 80°C for 6h, after purification, it was vacuum-dried to constant weight for later use.

[0059] The first step reaction product PEG-PCL and the second step reaction product PEG-PCL-PEG were characterized by infrared spectroscopy. The result is as figure 1 with 2 shown, from figure 1 It can be seen from the figure that there is a strong carbonyl absorption peak in the 1700-1750 band, which means that the reaction between ε-CL and MPEG forms an ester bond; from figure 2 It can be seen that there is no absorption peak between 2250 and 2270, indicating that HMDI is fully involved in the reaction to form PEG-PCL-PEG, and the characteristic absorption peak of the amide bond appears, which further proves the synthesis of PEG-PCL-PEG .

[0060] ...

Embodiment 3

[0069] (1) Weigh 2.14g MPEG and 6.67gε-CL(n (MPEG) :n (ε-CL) 1:15) and round bottom flask, add 0.05g stannous octoate (Sn(Oct) 2 ) After reacting at 100°C for 15h, add 0.65g HMDI (n (ε-CL) :n (HMDI) The ratio of 15:1) was reacted at 50°C for 9h, after purification, it was vacuum-dried to constant weight for later use.

[0070] (2) Weigh 0.40g of PECE, 0.50g of hydrogenated soybean lecithin (HSPC), 0.10g of cholesterol, and 0.05mL of BHA and dissolve them in 10mL of chloroform to make an organic phase solution;

[0071] (3) Dissolve 160mg / mL MA solution in the organic phase solution prepared in step (2), and then stir at 800r / min for 3min to form a W / O emulsion; then add the above W / O emulsion to 160mg / mL MA In the aqueous solution, stir for the second time at 800r / min for 3min to form W / O / W double emulsion;

[0072] (4) Transfer the W / O / W double emulsion in step (3) to an eggplant-shaped bottle, and remove the organic solvent by evaporating under reduced pressure with a r...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
pore sizeaaaaaaaaaa
particle diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses a PEG-PCL-PEG triblock copolymer modified madecassoside (MA) liposome and application thereof, belonging to the fields of pharmaceutical preparations, skin care products and daily chemical products. The MA liposome is prepared from the following components: a PEG-PCL-PEG triblock polymer, MA, cholesterol and lipid, wherein the MA is encapsulated in a liposome. The MA liposome is modified by the PEG-PCL-PEG triblock polymer, so that the fitting effect of a drug and the skin can be improved; especially, when being applied to the skin, the PEG-PCL-PEG triblock copolymer modified MA liposome can be converted into cream from liquid, thus achieving an effect of drug storage; therefore, the time of action between the MA and the skin is prolonged, the effect of long-actingslow release is realized, and the treatment effect is enhanced. A preparation method provided by the invention is simple in technology and easy to amplify; the PEG-PCL-PEG triblock copolymer modifiedMA liposome has wide application prospects in the aspects of later large-scale medical production and potential medical use.

Description

technical field [0001] The invention belongs to the fields of pharmaceutical preparations, skin care products and daily chemicals, and in particular relates to a madecassoside liposome modified by a PEG-PCL-PEG triblock copolymer and an application thereof. Background technique [0002] Madecassoside (Madecassoside, MA) is a triterpene saponin in the extract of Centella asiatica. It has good water solubility, contains three sugar chains in its structure, and has a large molecular weight. Clinically, it is widely used as the main ingredient in medicines for treating surgical wounds, scalds, burns and other skin wounds. It has various pharmacological effects such as antibacterial, anti-inflammatory, and promotion of fibroblast regeneration. However, because they are polar macromolecules, they are not easy to reach the lesion through the skin epidermis, so their efficacy and application are limited. [0003] Liposomes are vesicles that are spontaneously formed from phospholipi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/127A61K47/34A61K31/7024A61P17/02A61K8/90A61K8/60A61K8/14A61Q19/00A61Q19/08A61Q19/02
CPCA61K8/14A61K8/602A61K8/90A61K9/0002A61K9/1271A61K31/7024A61K47/34A61Q19/00A61Q19/02A61Q19/08
Inventor 刘美凤董礁礁
Owner SOUTH CHINA UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap